The Board of Directors of KIMS Hospitals has approved the merger of its wholly-owned subsidiaries, KIMS Hospitals Private Limited and Chalasani Hospitals Private Limited, with the holding company, Krishna Institute of Medical Sciences Limited. The decision was made at a board meeting held on November 7, 2025. The merger aims to streamline operations and enhance efficiency within the group.
Merger of Wholly-Owned Subsidiaries
KIMS Hospitals has announced the approval of a merger involving its wholly-owned subsidiaries. KIMS Hospitals Private Limited (Transferor Company-1) and Chalasani Hospitals Private Limited (Transferor Company-2) will merge with the parent company, Krishna Institute of Medical Sciences Limited (Transferee Company). This decision occurred during the board meeting on November 7, 2025.
Financial Performance: Q2 & Half-Year 2025
The board also approved the unaudited standalone and consolidated financial results for the second quarter (Q2: Jul-Sep) and half-year ended September 30, 2025. These results were reviewed by the Audit Committee. Key financial highlights include:
Standalone Financial Results (₹ in millions)
Revenue from operations for the quarter ended September 30, 2025: ₹4,300 compared to ₹3,633 for the same quarter last year.
Total Income for the quarter: ₹4,425
Profit before tax: ₹861
Profit for the period: ₹635
Consolidated Financial Results (₹ in millions)
Revenue from operations for the quarter ended September 30, 2025: ₹9,607 compared to ₹7,773 for the same quarter last year.
Total Income for the quarter: ₹9,649
Profit before tax: ₹968
Profit for the period: ₹720
Availability of Financial Results
The complete financial results are available on the company’s website and on the websites of BSE and NSE.
Source: BSE
